BJDX
Bluejay Diagnostics, Inc.
Bluejay Diagnostics, Inc. (BJDX) has 1 SEC Form 4 filing (2 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jul 13, 2026.
- Industry:Medical - Devices
- CEO:Indranil Dey
- Employees:6
- HQ:Acton, MA, US
- IPO:2021-11-10
Insider Buying
$97K
reported purchases (SEC code P)
Insider Selling
$49K
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$1.4M
latest known value
Related companies
Bluejay Diagnostics, Inc. is in the Healthcare sector.